GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Price-to-Operating-Cash-Flow

ABL Diagnostics (XPAR:ABLD) Price-to-Operating-Cash-Flow : 126.67 (As of Jun. 08, 2024)


View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Price-to-Operating-Cash-Flow?

As of today (2024-06-08), ABL Diagnostics's share price is €3.04. ABL Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.02. Hence, ABL Diagnostics's Price-to-Operating-Cash-Flow Ratio for today is 126.67.

The historical rank and industry rank for ABL Diagnostics's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:ABLD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.77   Med: 81.25   Max: 402
Current: 126.67

During the past 13 years, ABL Diagnostics's highest Price-to-Operating-Cash-Flow Ratio was 402.00. The lowest was 6.77. And the median was 81.25.

XPAR:ABLD's Price-to-Operating-Cash-Flow is ranked worse than
94.78% of 460 companies
in the Healthcare Providers & Services industry
Industry Median: 12.79 vs XPAR:ABLD: 126.67

ABL Diagnostics's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.02.

During the past 13 years, ABL Diagnostics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -64.50% per year. The lowest was -64.50% per year. And the median was -64.50% per year.


ABL Diagnostics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ABL Diagnostics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Price-to-Operating-Cash-Flow Chart

ABL Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.63 - 98.33 - -

ABL Diagnostics Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ABL Diagnostics's Price-to-Operating-Cash-Flow

For the Health Information Services subindustry, ABL Diagnostics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Price-to-Operating-Cash-Flow falls into.



ABL Diagnostics Price-to-Operating-Cash-Flow Calculation

ABL Diagnostics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3.04/0.024
=126.67

ABL Diagnostics's Share Price of today is €3.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ABL Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

ABL Diagnostics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Diagnostics (XPAR:ABLD) Business Description

Traded in Other Exchanges
N/A
Address
72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines